Maternal-Fetal Genotype Incompatibility and Rheumatoid Arthritis Risk
Author Information
Author(s): Hsieh Hsin-Ju, Palmer Christina GS, Harney Sinead, Chen Hsiu-Wen, Bauman Lara, Brown Matthew A, Sinsheimer Janet S
Primary Institution: Genentech, Inc.
Hypothesis
Is non-inherited maternal HLA-DRB1 antigen coding alleles a risk factor for rheumatoid arthritis?
Conclusion
The study found no evidence that non-inherited maternal HLA-DRB1 alleles are a risk factor for rheumatoid arthritis.
Supporting Evidence
- The study used data from the North American Rheumatoid Arthritis Consortium.
- Significant offspring allelic effects on RA risk were found.
- The MFG test is robust to population stratification.
- Previous studies reported conflicting results regarding NIMA effects.
- Only families with at least one parent genotyped were included in the analysis.
- 263 nuclear families were analyzed after exclusions.
- Power analysis indicated the study could detect smaller effect sizes.
Takeaway
The study looked at whether certain genes from mothers could make their children more likely to get rheumatoid arthritis, but they didn't find any proof that this is true.
Methodology
The study used the maternal-fetal genotype incompatibility (MFG) test to analyze HLA-DRB1 genotype data from families with rheumatoid arthritis.
Potential Biases
Potential biases due to the exclusion of families without parental genotypes.
Limitations
The study's sample size may be too small to detect small NIMA effects.
Participant Demographics
The families were predominantly Caucasian with some African, Hispanic, Native American, and Asian minorities.
Statistical Information
P-Value
1.5 × 10-28
Statistical Significance
p = 0.8956
Want to read the original?
Access the complete publication on the publisher's website